3 min read
NDMA Contamination in Metformin: Detection, Risks, and Best Practices
The issue of NDMA contamination in pharmaceuticals like metformin has become an industry-wide focus due to its...
Cannabinoid Profiling in Medicinal Cannabis
RELIABLE GC POTENCY TESTING WITH THE 200 SERIES GC FOR SAFER, ACCURATE DOSING
The Challenge
Cannabis derived medicines are widely used for managing epilepsy, chronic pain, and other conditions but with inconsistent labelling and natural variation between strains, ensuring correct cannabinoid dosage is a challenge. Regulatory bodies like the FDA have flagged major discrepancies in product content versus label claims. This can risk patient safety, undercut clinical trust, and invite legal repercussions.
A Different Approach
Ellutia provides a precise, reproducible method for cannabinoid quantification using the 200 Series GC paired with liquid autosampling. Designed specifically for medicinal cannabis workflows, this system simplifies accurate THC, CBD, and CBN profiling across oils, tinctures, and edibles without the need for complex lab setups.
WHY CANNABINOID PROFILING MATTERS
-
Therapeutic Accuracy: Minor shifts in cannabinoid ratios can dramatically impact clinical outcomes.
-
Regulatory Integrity: With global moves toward full chemical transparency, potency accuracy is no longer optional.
-
Patient Safety: Under‑ or over‑labelling of THC/CBD content can lead to serious side effects or ineffective treatment.
PRODUCT QUALITY & REPUTATION
Routine cannabinoid analysis improves:
-
Batch‑to‑batch consistency
-
Label accuracy for product trust
-
Legal defensibility in the event of audit or patient complaint
Regulatory Compliance
Mislabelled products have already triggered FDA warnings. Potency testing using 200 Series GC supports alignment with MHRA, FDA, and EU‑GMP expectations for medicinal cannabis ensuring reliable dosing, transparent labelling, and traceable records.
RELIABLE RESULTS WITHOUT COMPLEX SAMPLE PREP
Unlike methods requiring headspace, Ellutia’s workflow uses liquid injection proven more representative for complex cannabis matrices. The system delivers:
-
Pre‑set method files via Ellution software
-
Clear resolution of THC, CBD, CBN and other markers
-
Repeatable results across batches and product types
OUR ANALYTICAL SOLUTION
The 200 Series GC offers a practical, compact solution for cannabis potency testing. Designed to work with liquid injection methods, it accurately quantifies cannabinoids like Delta‑THC, CBD, and CBN across medicinal cannabis products.
Whether you're testing flower, oils, or edibles, the 200 Series GC delivers fast, reliable results while keeping workflows efficient.
Key Features:
-
Compatible with FID for high‑sensitivity detection
-
Supports repeatable analysis of THC, CBD, CBN, and other cannabinoids
-
Validated GC conditions and pre‑set method files for immediate deployment
-
Compact design ideal for labs with limited space
-
Optional integration with EL3100A or EL3000A liquid autosamplers
About Us
At Ellutia, we help cannabis producers, formulators, and testing labs ensure product quality through robust, easy-to-implement GC workflows. Backed by decades of chromatographic innovation, we enable clients to meet patient needs, safeguard compliance, and protect their brand.
Get in touch
Tell us about your testing requirements.
MISSED OUR WEBINAR? DETECTING UNEXPECTED NITROSAMINE CONTAMINATION
One of the biggest challenges in nitrosamine analysis is identifying contaminants you’re not expecting. Standard testing methods like GC or LC can detect known nitrosamines but only if you have the right reference standards. Unexpected nitrosamines, however, can easily go unnoticed.
In this webinar, we explore practical analytical strategies that can help uncover potential nitrosamine contaminants even when specific standards aren't available. If your current methods rely heavily on predefined targets, this session will highlight ways to reduce risk and gain a clearer picture of contamination.
INTERESTED IN IMPROVING YOUR TESTING STRATEGY OR WANT ACCESS TO THE RECORDING?
